| pubmed-article:16968587 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16968587 | lifeskim:mentions | umls-concept:C0030551 | lld:lifeskim |
| pubmed-article:16968587 | lifeskim:mentions | umls-concept:C0728836 | lld:lifeskim |
| pubmed-article:16968587 | lifeskim:mentions | umls-concept:C0684224 | lld:lifeskim |
| pubmed-article:16968587 | lifeskim:mentions | umls-concept:C0700287 | lld:lifeskim |
| pubmed-article:16968587 | lifeskim:mentions | umls-concept:C0271429 | lld:lifeskim |
| pubmed-article:16968587 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:16968587 | lifeskim:mentions | umls-concept:C0060405 | lld:lifeskim |
| pubmed-article:16968587 | lifeskim:mentions | umls-concept:C1244601 | lld:lifeskim |
| pubmed-article:16968587 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:16968587 | pubmed:dateCreated | 2006-9-13 | lld:pubmed |
| pubmed-article:16968587 | pubmed:abstractText | To compare efficacy, tolerability, and parental satisfaction of cefdinir and high-dose amoxicillin/clavulanate oral suspensions given to young children with non-refractory acute otitis media (AOM) based on clinical endpoints and outcomes measures. | lld:pubmed |
| pubmed-article:16968587 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16968587 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16968587 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16968587 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16968587 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16968587 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16968587 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16968587 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:16968587 | pubmed:issn | 0300-7995 | lld:pubmed |
| pubmed-article:16968587 | pubmed:author | pubmed-author:HalpernMichae... | lld:pubmed |
| pubmed-article:16968587 | pubmed:author | pubmed-author:NiliusAngela... | lld:pubmed |
| pubmed-article:16968587 | pubmed:author | pubmed-author:BusmanTodd... | lld:pubmed |
| pubmed-article:16968587 | pubmed:author | pubmed-author:NotarioGerard... | lld:pubmed |
| pubmed-article:16968587 | pubmed:author | pubmed-author:SchmierJordan... | lld:pubmed |
| pubmed-article:16968587 | pubmed:author | pubmed-author:BlockStan LSL | lld:pubmed |
| pubmed-article:16968587 | pubmed:author | pubmed-author:AkinladeBolan... | lld:pubmed |
| pubmed-article:16968587 | pubmed:author | pubmed-author:MackinnonGeor... | lld:pubmed |
| pubmed-article:16968587 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16968587 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:16968587 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16968587 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16968587 | pubmed:pagination | 1839-47 | lld:pubmed |
| pubmed-article:16968587 | pubmed:meshHeading | pubmed-meshheading:16968587... | lld:pubmed |
| pubmed-article:16968587 | pubmed:meshHeading | pubmed-meshheading:16968587... | lld:pubmed |
| pubmed-article:16968587 | pubmed:meshHeading | pubmed-meshheading:16968587... | lld:pubmed |
| pubmed-article:16968587 | pubmed:meshHeading | pubmed-meshheading:16968587... | lld:pubmed |
| pubmed-article:16968587 | pubmed:meshHeading | pubmed-meshheading:16968587... | lld:pubmed |
| pubmed-article:16968587 | pubmed:meshHeading | pubmed-meshheading:16968587... | lld:pubmed |
| pubmed-article:16968587 | pubmed:meshHeading | pubmed-meshheading:16968587... | lld:pubmed |
| pubmed-article:16968587 | pubmed:meshHeading | pubmed-meshheading:16968587... | lld:pubmed |
| pubmed-article:16968587 | pubmed:meshHeading | pubmed-meshheading:16968587... | lld:pubmed |
| pubmed-article:16968587 | pubmed:meshHeading | pubmed-meshheading:16968587... | lld:pubmed |
| pubmed-article:16968587 | pubmed:meshHeading | pubmed-meshheading:16968587... | lld:pubmed |
| pubmed-article:16968587 | pubmed:meshHeading | pubmed-meshheading:16968587... | lld:pubmed |
| pubmed-article:16968587 | pubmed:meshHeading | pubmed-meshheading:16968587... | lld:pubmed |
| pubmed-article:16968587 | pubmed:meshHeading | pubmed-meshheading:16968587... | lld:pubmed |
| pubmed-article:16968587 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16968587 | pubmed:articleTitle | Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children. | lld:pubmed |
| pubmed-article:16968587 | pubmed:affiliation | Kentucky Pediatric/Adult Research, Bardstown, KY 40004, USA. slblock@pol.net | lld:pubmed |
| pubmed-article:16968587 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16968587 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16968587 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16968587 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:16968587 | pubmed:publicationType | Clinical Trial, Phase IV | lld:pubmed |
